RxDoctor Payments Data

John Goldenring

Pediatrics · la Mesa, CANPI 1063521961

Payments from drug & device makers

$89,722in general payments, 2019–2025

Across 84 payments — averaging $1068.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim International GmbH$16K
  • Genentech USA, Inc.$13K
  • Genentech, Inc.$9K
  • Gilead$8K
  • Novo Nordisk AS$7K
  • Genmab U.S., Inc.$7K
  • plus $30K from 10 others

What the payments were for

  • Consulting fees$66,17974%
  • Speaking & faculty fees$9,60011%
  • Travel & lodging$11,42513%
  • Food & beverage$2,5193%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$89,722 in reported general payments places this provider in the 95th percentile of 5,539 pediatrics providers in California.

See all pediatrics providers in California

Other pediatrics in la Mesa

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →